Emcure Pharmaceuticals Ltd Board of Directors

Home

Insights

Board of Directors

₹ 3.3 Cr

Volume Transacted

(Nov 8, 2024)

23.4 K

Stocks Traded

(Nov 8, 2024)

Last Updated on: Nov 09, 2024

Board of Directors at Emcure Pharmaceuticals Ltd

Name	Designation

Berjis Desai	Chairman & Independent Directo
CHETAN SHARMA	Company Sec. & Compli. Officer
MUKUND GURJAR	Whole Time Director
NAMITA THAPAR	Whole Time Director
P Jayakumar	Independent Director

Name	Designation
Berjis Desai	Chairman & Independent Directo
CHETAN SHARMA	Company Sec. & Compli. Officer
MUKUND GURJAR	Whole Time Director
NAMITA THAPAR	Whole Time Director
P Jayakumar	Independent Director

Open Demat Account

Enter your mobile no. to continue

+91

*By signing up you agree to our terms & conditions

50 Years

of Trust & Legacy

₹0 AMC

for First Year

₹0 Brokerage

on Delivery, Intraday, Currency and NSE F&O

Key Highlights

MUKUND KESHAO GURJAR continues to serve as the Whole Time Director in 2024, maintaining the same position as in the previous year.
SUNIL RAJNIKANT MEHTA continues to serve as the Whole Time Director in 2024, maintaining the same position as in the previous year.
SATISH RAMANLAL MEHTA continues to serve as the Managing Director & CEO in 2024, maintaining the same position as in the previous year.
Berjis M Desai continues to serve as the Chairman & Independent Directo in 2024, maintaining the same position as in the previous year.
NAMITA VIKAS THAPAR continues to serve as the Whole Time Director in 2024, maintaining the same position as in the previous year.

Emcure Pharmaceuticals Ltd

NSE: EMCURE

PRICE

Last updated on:

Last Ten Days Market Price

Date	Price (₹)	Day Open (₹)	Day High (₹)	Day Low (₹)

08 Nov 2024	1396.85	1498.95	1523.8	1380.1
07 Nov 2024	1437.35	1440	1456	1425
06 Nov 2024	1444.25	1455.55	1459.15	1427.6
05 Nov 2024	1441.55	1455	1455	1428
04 Nov 2024	1440.4	1401.4	1454	1401.4
01 Nov 2024	1442	1445.85	1460.05	1420
31 Oct 2024	1444.7	1416	1465.35	1416
30 Oct 2024	1444.6	1386.25	1457.7	1386.25
29 Oct 2024	1407.3	1385.3	1427.15	1384.05
28 Oct 2024	1407.25	1374.95	1413.75	1355.25

Date	Price (₹)
08 Nov 2024	1396.85
07 Nov 2024	1437.35
06 Nov 2024	1444.25
05 Nov 2024	1441.55
04 Nov 2024	1440.4
01 Nov 2024	1442
31 Oct 2024	1444.7
30 Oct 2024	1444.6
29 Oct 2024	1407.3
28 Oct 2024	1407.25

Company Fundamentals for Emcure Pharmaceuticals Ltd

Market Cap

₹ 26,414 Cr

EPS

₹ 30.4

P/E Ratio (TTM) *

46.0

P/B Ratio (TTM) *

6.4

Day’s High *

1523.8

Day’s Low

₹ 1380.1

DTE *

0.3

ROE *

13.8

52 Week High

₹ 1577.5

52 Week Low

₹ 1226.5

ROCE *

18.7

PRICE

The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.

Market Price Over Time

Monitoring Emcure Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Emcure Pharmaceuticals Ltd News Hub

Emcure Pharma Q2 PAT rises 38.2% YoY

In Q2FY25, the drug maker's consolidated revenue from operations stood at Rs 2,002 crore, ...

08 Nov 202412:50

Emcure Pharmaceuticals to hold board meeting

Emcure Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 7 N...

02 Nov 202413:58

Emcure Pharmaceuticals to announce Quarterly Result

Emcure Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 7 N...

31 Oct 202410:43

Emcure signs licensing agreement with Gilead Sciences

Emcure Pharmaceuticals announced the signing of a royalty-free voluntary licensing agreeme...

03 Oct 202410:15

Emcure Pharmaceuticals receives upgrade in credit ratings for bank facilities

Emcure Pharmaceuticals announced that CARE Ratings has upgraded the credit ratings assigne...

13 Aug 202419:01

Emcure Pharmaceuticals receives upgrade in credit ratings from CRISIL

Emcure Pharmaceuticals has received upgrade in credit ratings from CRISIL for bank facilit...

13 Aug 202419:03

Document

Annual Reports

N/A

Credit Ratings

N/A

Concalls

Data not available

Emcure Pharmaceuticals Ltd market cap

Emcure Pharmaceuticals Ltd share price history

Emcure Pharmaceuticals Ltd isin code

Sun Pharmaceuticals Industries Ltd board of directors

Divis Laboratories Ltd board of directors

Cipla Ltd board of directors

Mankind Pharma Ltd board of directors

Dr Reddys Laboratories Ltd board of directors

Torrent Pharmaceuticals Ltd board of directors

Zydus Lifesciences Ltd board of directors

Lupin Ltd board of directors

Aurobindo Pharma Ltd board of directors

Alkem Laboratories Ltd board of directors

FAQs for Board of Directors of Emcure Pharmaceuticals Ltd

How are members of Emcure Pharmaceuticals Ltd Board of Directors selected?

Members of the Emcure Pharmaceuticals Ltd Board of Directors are typically selected based on their expertise, experience, and alignment with Emcure Pharmaceuticals Ltd’s strategic goals. Appointments are made by the nomination and remuneration committee and approved by shareholders. However, the selection process does vary from company to company.

Can shareholders interact with the Emcure Pharmaceuticals Ltd Board of Directors?

Shareholders can interact with the Emcure Pharmaceuticals Ltd Board of Directors during the Annual General Meeting (AGM) and through formal communications or queries submitted to the company wherein they have the opportunity to ask questions and provide feedback on the business. Please note different companies have different protocols for shareholders who want to meet the Board of Directors.

How often does the Emcure Pharmaceuticals Ltd Board of Directors meet?

The Emcure Pharmaceuticals Ltd Board of Directors typically meets quarterly. However, special meetings may be summoned as needed to address urgent matters. The frequency can vary depending on business needs and regulatory requirements to ensure ongoing oversight and strategic guidance for the company. A scheduled meeting among the Board of Directors may vary from company to company.

What are the responsibilities of the Emcure Pharmaceuticals Ltd Board of Directors?

The Emcure Pharmaceuticals Ltd Board of Directors is responsible for setting strategic goals, overseeing company performance, ensuring effective governance, and safeguarding shareholder interests. They provide high-level guidance on corporate policies and risk management. Additionally, they appoint and evaluate senior management and ensure compliance with legal and regulatory requirements. Please note the roles and responsibilities of the Board of Directors may be different from company to company.

Who are the current members of the Board of Directors at Emcure Pharmaceuticals Ltd?

The current Board of Directors at Emcure Pharmaceuticals Ltd includes MUKUND KESHAO GURJAR( Whole Time Director) ,SUNIL RAJNIKANT MEHTA( Whole Time Director) ,SATISH RAMANLAL MEHTA( Managing Director & CEO) ,Berjis M Desai( Chairman & Independent Directo) ,NAMITA VIKAS THAPAR( Whole Time Director) . The full list can be found on Emcure Pharmaceuticals Ltd’s official website or recent corporate filings.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.

Unlimited trading at just

~~Rs. 399~~

Rs. 199*

Emcure Pharmaceuticals Ltd Board of Directors

Board of Directors at Emcure Pharmaceuticals Ltd

Key Highlights

Last Ten Days Market Price

Company Fundamentals for Emcure Pharmaceuticals Ltd

PRICE

Market Price Over Time

Emcure Pharmaceuticals Ltd News Hub

Document

Popular Search